Sanofi (OTCMKTS:SNYNF – Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 224,051 shares, a growth of 103.3% from the October 15th total of 110,212 shares. Based on an average daily volume of 4,811 shares, the short-interest ratio is presently 46.6 days.
Sanofi Stock Down 0.4%
Shares of SNYNF traded down $0.36 during mid-day trading on Monday, reaching $96.45. The company had a trading volume of 1,239 shares, compared to its average volume of 24,707. The firm has a fifty day simple moving average of $84.65 and a 200-day simple moving average of $88.31. Sanofi has a fifty-two week low of $76.76 and a fifty-two week high of $106.34.
About Sanofi
Sanofi is a France-based global healthcare company focused on the research, development, manufacturing and commercialization of pharmaceutical products and vaccines. Its portfolio includes medicines for immunology, rare diseases, neurology, oncology and other specialty-care areas, as well as treatments for common conditions such as diabetes and cardiovascular disease. The company’s well-known products include Dupixent, an immunology medicine developed with Regeneron; vaccines marketed through its Vaccines division, including influenza and travel vaccines; and established prescription medicines in several therapeutic categories.
See Also
- Five stocks we like better than Sanofi
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
